Matching coronary blood flow to myocardial oxygen consumption

Journal of Applied Physiology

Volumn 97, Issue 1, 2004, Pages 404-415

  Tune, Johnathan D ^b   Gorman, Mark W ^a   Feigl, Eric O ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; ATP dependent K+ channels; Feedback control; Feedforward control; Nitric oxide; Norepinephrine

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CARBON DIOXIDE; ENDOTHELIN; ENDOTHELIN 1; NITRIC OXIDE; OXYGEN; POTASSIUM CHANNEL; PROSTAGLANDIN;

ADRENERGIC SYSTEM; ATP DEPENDENT POTASSIUM CHANNEL; BLOOD FLOW; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; EXERCISE; FEEDBACK SYSTEM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART RATE; METABOLIC REGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ADENOSINE; ANIMALS; BIOLOGICAL FACTORS; CARBON DIOXIDE; CORONARY CIRCULATION; ENDOTHELINS; HEART; HUMANS; MEMBRANE PROTEINS; MYOCARDIUM; NITRIC OXIDE; OXYGEN CONSUMPTION; POTASSIUM CHANNELS; PROSTAGLANDINS; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASODILATION;

EID: 3042657046     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01345.2003     Document Type: Review

References (210)

1. Afonso S, Bandow GT, and Rowe GG. Indomethacin and the prostaglandin hypothesis of coronary blood flow regulation. J Physiol 241: 299-308, 1974.
2. 2 receptor mediated coronary vasodilatation in the dog. Cardiovasc Res 28: 906-911, 1994.
3. Alexander RW, Kent KM, Pisano JJ, Keiser HR, and Cooper T. Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest 55: 1174-1181, 1975.
4. Altman JD, Kinn J, Duncker DJ, and Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28: 119-124, 1994.
5. Amezcua JL, Palmer RMJ, de Souza BM, and Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 97: 1119-1124, 1989.
6. 1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther 266: 611-617, 1993.
7. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, and Trovati M. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105: 71-78, 2002.
8. Angello DA, Berne RM, and Coddington NM. Adenosine and insulin mediate glucose uptake in normoxic rat hearts by different mechanisms. Am J Physiol Heart Circ Physiol 265: H880-H885, 1993.
9. Ashcroft SJ and Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal 2: 197-214, 1990.
10. ATP channels, and ischemic preconditioning in dogs. Am J Physiol Heart Circ Physiol 264: H1327-H1336, 1993.
11. Aversano T, Ouyang P, and Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 69: 618-622, 1991.
12. Awolesi MA, Sessa WC, and Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 96: 1449-1454, 1995.
13. Bacchus AN, Ely SW, Knabb RM, Rubio R, and Berne RM. Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli. Am J Physiol Heart Circ Physiol 243: H628-H633, 1982.
14. 1-adrenergic blockade on coronary blood flow during exercise. Circ Res 61: II36-II41, 1987.
15. Bache RJ, Dai XZ, Schwartz JS, and Homans DC. Role of adenosine in coronary vasodilation during exercise. Circ Res 62: 846-853, 1988.
16. Bassingthwaighte JB. Interstitial adenosine: the measurement, the interpretation. J Mol Cell Cardiol 24: 337-346, 1992.
17. Belardinelli L, Linden J, and Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 32: 73-97, 1989.
18. Belloni FL and Hintze TH. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilation. Am J Physiol Heart Circ Physiol 261: H720-H727, 1991.
19. Berdeaux A, Ghaleh B, Dubois-Randé JL, Vigué B, la Rochelle CD, Hittinger L, and Giudicelli JF. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation 89: 2799-2808, 1994.
20. Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204: 317-322, 1963.
21. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res 47: 807-813, 1980.
22. Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, and Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 79: 840-848, 1996.
23. Block AJ, Poole S, and Vane JR. Modification of basal release of prostaglandins from rabbit isolated hearts. Prostaglandins 7: 473-486, 1974.
24. Broten TP and Feigl EO. Role of myocardial oxygen and carbon dioxide in coronary autoregulation. Am J Physiol Heart Circ Physiol 262, H1231-H1237, 1992.
25. Broten TP, Romson JL, Fullerton DA, Van Winkle DM, and Feigl EO. Synergistic action of myocardial oxygen and carbon dioxide in controlling coronary blood flow. Circ Res 68: 531-542, 1991.
26. Bruckner R, Fenner A, Meyer W, Nobis TM, Schmitz W, and Scholz H. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacal Exp Ther 234: 766-774, 1985.
27. Buga GM, Gold ME, Fukuto JM, and Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17: 187-193, 1991.
28. Busse R, Pohl U, and Luckhoff A. Mechanisms controlling the production of endothelial autacoids. Z Kardiol 78, Suppl 6: 64-69, 1989.
29. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
30. Canty JM and Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 89: 375-384, 1994.
31. Chilian WM, Layne SM, Eastham CL, and Marcus ML. Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circ Res 64: 376-388, 1989.
32. Chu A, Chambers DE, Lin CC, Kuehl WD, and Cobb FR. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol Heart Circ Physiol 258: H1250-H1254, 1990.
33. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RMJ, Moncada S, and Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87: 1964-1968, 1991.
34. Clayton FC, Hess TA, Smith MA, and Grover GJ. Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism. Pharmacology 44: 92-100, 1992.
35. + channels in pancreatic B-cells. Nature 311: 271-273, 1984.
36. Cousineau D, Goresky CA, Bach GG, and Rose CP. Effect of β-adrenergic blockade on in vivo norepinephrine release in canine heart. Am J Physiol Heart Circ Physiol 246: H283-H292, 1984.
37. Cronstein BN, Kramer SB, Weissmann G, and Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158: 1160-1177, 1983.
38. Dai XZ and Bache RJ. Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol Heart Circ Physiol 247: H452-H458, 1984.
39. Dankelman J, Van der Ploeg CPB, and Spaan JAE. Glibenclamide decelerates the responses of coronary regulation in the goat. Am J Physiol Heart Circ Physiol 266: H1715-H1721, 1994.
40. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Günther K, and Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247: 1341-1344, 1990.
41. Davis CAI, Sherman AJ, Yaroshenko Y, Harris KR, Hedjbeli S, Parker MA, and Klocke FJ. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. J Am Coll Cardiol 31: 816-822, 1998.
42. 1-adrenergic constriction of coronary arterioles. Am J Physiol Heart Circ Physiol 276: H1028-H1034, 1999.
43. Degubareff T and Sleator W Jr. Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium. J Pharmacol Exp Ther 148: 202-214, 1965,
44. 2. J Mol Cell Cardiol 23: 495-504, 1991.
45. DiMarco JP, Sellers TD, Berne RM, West GA, and Belardinelli L. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68: 1254-1263, 1983.
46. DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, and Belardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 6: 417-425, 1985.
47. DiSaivo J, Parker PE, Scott JB, and Haddy FJ. Carotid baroceptor influence on coronary vascular resistance in the anesthetized dog. Am J Physiol 221: 156-160, 1971.
48. Dobson JG Jr. Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res 52: 151-160, 1983.
49. Dobson JG Jr, Ordway RW, and Fenton RA. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol Heart Circ Physiol 251: H455-H462, 1986.
50. Dobson JG Jr and Schrader J. Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol 16: 813-822, 1984.
51. Downey HF, Merrill GF, Yonekura S, Watanabe N, and Jones CE. Adenosine deaminase attenuates norepinephrine-induced coronary functional hyperemia. Am J Physiol Heart Circ Physiol 254: H417-H424, 1988.
52. Duffy SJ, Castle SF, Harper RW, and Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation 100: 1951-1957, 1999.
53. Duncker DJ and Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 74: 629-640, 1994.
54. Duncker DJ, Laxson DD, Lindstrom P, and Bache RJ. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise. Cardiovasc Res 27: 1592-1597, 1993.
55. + channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol 280: H22-H33, 2001.
56. Duncker DJ, Stubenitsky R, and Verdouw PD. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise: evidence for feed-forward β-adrenergic control. Circ Res 82: 1312-1322, 1998.
57. Duncker DJ, Stubenitsky R, and Verdouw PD. Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol Heart Circ Physiol 275: H1663-H1672, 1998.
58. ATP channels in coronary vasodilation during exercise. Circulation 88: 1245-1253, 1993.
59. ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J CIin Invest 97: 996-1009, 1996.
60. ATP channel blockade. J Clin Invest 95: 285-295, 1995.
61. Edlund A, Berglund B, van Dorne D, Kaijser L, Nowak J, Patrono C, Sollevi A, and Wennmalm A. Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation. Circulation 71: 1113-1120, 1985.
62. Edlund A, Conradsson T, and Sollevi A. A role for adenosine in coronary vasoregulation in man. Effects of theophylline and enprofylline. Clin Physiol 15: 623-636, 1995.
63. Edlund A, Siden A, and Sollevi A. Evidence for an anti-aggregatory effect of adenosine at physiological concentrations and for its role in the action of dipyridamole. Thromb Res 45: 183-190, 1987.
64. Edlund A and Sollevi A. Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation. Acta Physiol Scand 155: 303-311, 1995.
65. Edlund A, Sollevi A and Wennmalm Å. The role of adenosine and prostacyclin in coronary flow regulation in healthy man. Acta Physiol Scand 135: 39-46, 1989.
66. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, and Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 79: 331-335, 1996.
67. Ek L and Åblad B. Effects of three beta adrenergic receptor blockers on myocardial oxygen consumption in the dog. Eur J Pharmacol 14: 19-28, 1971.
68. Ely SW, Knabb RM, Bacchus AN, Rubio R, and Berne RM. Measurements of coronary plasma and pericardial infusate adenosine concentrations during exercise in conscious dog: relationship to myocardial oxygen consumption and coronary blood flow. J Mol Cell Cardiol 15: 673-683, 1983.
69. Ely SW, Mentzer RM Jr, Lasley RD, Lee BK, and Berne RM. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90: 549-556, 1985.
70. Embrey RP, Brooks LA, and Dellsperger KC. Mechanism of coronary microvascular responses to metabolic stimulation. Cardiovasc Res 35: 148-157, 1997.
71. Fang HK, Sturgeon C, Segil LJ, Ripper RL, and Law WR. Cardiac contractile function during coronary stenosis in dogs: association of adenosine in glycolytic dependence. Am J Physiol Heart Circ Physiol 272: H2195-H2203, 1997.
72. Farouque HM, Worthley SG, Meredith IT, Skyrme-Jones RA, and Zhang MJ. Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. Circ Res 90: 231-236, 2002.
73. Favale S, Di Biase M, Rizzo U, Belardinelli L, and Rizzon P. Effect of adenosine and adenosine-5′-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol 5: 1212-1219, 1985.
74. Feigl EO. Sympathetic control of coronary circulation. Circ Res 20: 262-271, 1967.
75. Feigl EO. Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res 37: 88-95, 1975.
76. Feigl EO. Coronary physiology. Physiol Rev 63: 1-205, 1983.
77. Finegan BA, Lopaschuk GD, Coulson CS, and Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908, 1993.
78. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
79. Fleming I, Bauersachs J, and Busse R. Paracrine functions of the coronary vascular endothelium. Mol Cell Biochem 157: 137-145, 1996.
80. Friedman PL, Brown EJ Jr, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, and Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 305: 1171-1175, 1981.
81. Gerlach E, Deuticke B, and Dreisbach RH. Der Nucleotid-Abbau im Herzmuskel bei Sauerstoffmangel und seine mögliche Bedeutung für die Coronardurchblutung. Naturwissenschaften 50: 228-229, 1963.
82. Gidday JM, Hill HE, Rubio R, and Berne RM. Estimates of left ventricular interstitial fluid adenosine during catecholamine stimulation. Am J Physiol Heart Circ Physiol 254: H207-H216, 1988.
83. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 110: 1201-1205, 1993.
84. Gorman MW, Tune JD, Richmond KN, and Feigl EO. Feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 89: 1892-1902, 2000.
85. Gorman MW, Tune JD, Richmond KN, and Feigl EO. Quantitative analysis of feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 89: 1903-1911, 2000.
86. Gwirtz PA and Stone HL. Coronary blood flow and myocardial oxygen consumption after alpha adrenergic blockade during submaximal exercise. J Pharmacol Exp Ther 217: 92-98, 1981.
87. 2- Adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Am J Physiol Heart Circ Physiol 271: H1926-H1937, 1996.
88. Harder DR, Campbell WB, and Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32: 79-92, 1995.
89. Harlan DM, Rooke TW, Belioni FL, and Sparks HV. Effect of indomethacin on coronary vascular response to increased myocardial oxygen consumption. Am J Physiol Heart Circ Physiol 235: H372-H378, 1978.
90. Hart BJ, Bian X, Gwirtz PA, Setty S, and Downey HF. Right ventricular oxygen supply/demand balance in exercising dogs. Am J Physiol Heart Circ Physiol 281: H823-H830, 2001.
91. Headrick JP, Ely SW, Matherne GP, and Berne RM. Myocardial adenosine, flow, and metabolism during adenosine antagonism and adrenergic stimulation. Am J Physiol Heart Circ Physiol 264: H61-H70, 1993.
92. Headrick JP, Hack B, and Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 285: H1797-H1518, 2003.
93. Hein TW, Wang W, Zoghf B, Muthuchamy M, and Kuo L. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol 33: 271-282, 2001.
94. Heller LJ, Dole WP, and Mohrman DE. Adenosine receptor blockade enhances isoproterenol-induced increases in cardiac interstitial adenosine. J Mol Cell Cardiol 23: 887-898, 1991.
95. Heyndrickx GR, Muylaert P, and Pannier JL. α-Adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol Heart Circ Physiol 242: H805-H809, 1982.
96. Hintze TH and Kaley G. Prostaglandins and the control of blood flow in the canine myocardium. Circ Res 40: 313-320, 1977.
97. Hourani SM. Purinoceptors and platelet aggregation. J Auton Pharmacol 16: 349-352, 1996.
98. Hourani SM and Cusack NJ. Pharmacological receptors on blood platelets. Pharmacol Rev 43: 243-298, 1991.
99. Huang AH and Feigl EO. Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res 62: 286-298, 1988.
100. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, and Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol Heart Circ Physiol 263: H399-H404, 1992.
101. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82: 346-359, 1998.
102. Jesmok GJ, Gross GJ, and Hardman HF. The effect of adenosine on myocardial metabolism and oxygen consumption in the isolated dog heart preparation. J Mol Cell Cardiol 10: 249-261, 1978.
103. Jones AW, Rubin LJ, and Magliola L. Endothelin-1 sensitivity of porcine coronary arteries is reduced by exercise training and is gender dependent. J Appl Physiol 87: 1172-1177, 1999.
104. Jones CE, Hurst TW, and Randall JR. Effect of aminophylline on coronary functional hyperemia and myocardial adenosine. Am J Physiol Heart Circ Physiol 243: H480-H487, 1982.
105. 2- adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 87: 1264-1274, 1993.
106. Jones CJH, Kuo L, Davis MJ, and Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 29: 585-596, 1995.
107. Katnik C and Adams DJ. Characterization of ATP-sensitive potassium channels in freshly dissociated rabbit aortic endothelial cells. Am J Physiol Heart Circ Physiol 272: H2507-H2511, 1997.
108. Kauser K and Rubanyi GM. Bradykinin-induced, N omega-nitro-Larginine- insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances. J Cardiovasc Pharmacol 20, Suppl 12: S101-S104, 1992.
109. Knabb RM, Ely SW, Bacchus AN, Rubio R, and Berne RM. Consistent parallel relationships among myocardial oxygen consumption, coronary blood flow, and pericardial infusate adenosine concentration with various interventions and β-blockade in the dog. Circ Res 53: 33-41, 1983.
110. Koller A, Sun D, and Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 72: 1276-1284, 1993.
111. Kroll K and Feigl EO. Adenosine is unimportant in controlling coronary blood flow in unstressed dog hearts. Am J Physiol Heart Circ Physiol 249: H1176-H1187, 1985.
112. Kroll K and Stepp DW. Adenosine kinetics in the canine coronary circulation. Am J Physiol Heart Circ Physiol 270: H1469-H1483, 1996.
113. ATP channels in endothelium. Am J Physiol Heart Circ Physiol 269: H541-H549, 1995.
114. Kuo L, Davis MJ, and Chilian WM. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 259: H1063-H1070, 1990.
115. Kusachi S and Olsson RA. Pericardial superfusion to measure cardiac interstitial adenosine concentration. Am J Physiol Heart Circ Physiol 244: H458-H461, 1983.
116. Lamontagne D, Pohl U, and Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70: 123-130, 1992.
117. Laughlin MH and Muller JM. Vasoconstrictor responses of coronary resistance arteries in exercise-trained pigs. J Appl Physiol 84: 884-889, 1998.
118. Lavallee M and Thorin E. Role of ET-1 in the regulation of coronary circulation. Can J Physiol Pharmacol 81: 570-577, 2003.
119. Law WR, McLane MP, and Raymond RM. Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes 37: 842-845, 1988.
120. Law WR and Raymond RM. Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivo. Am J Physiol Heart Circ Physiol 254: H970-H975, 1988.
121. Laxson DD, Homans DC, and Bache RJ. Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. Am J Physiol Heart Circ Physiol 265: H1471-H1477, 1993.
122. Lefroy DC, Crake T, Uren NG, Davies GJ, and Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 88: 43-54, 1993.
123. Lerman BB and Belardinelli L. Effect of adenosine on ventricular tachycardia. Prog Clin Biol Res 230: 301-314, 1987.
124. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
125. MacCarthy PA, Pegge NC, Pendergast BD, Shah AM, and Groves PH. The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol 37: 137-143, 2001.
126. Maekawa K, Saito D, Obayashi N, Uchida S, and Haraoka S. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol Heart Circ Physiol 267: H166-H173, 1994.
127. Maggirwar SB, Dhanraj DN, Somani SM, and Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201: 508-515, 1994.
128. 2 utilization efficiency in isoprenaline-stimulated canine myocardium. Cardiovasc Res 31: 102-116, 1996.
129. Manfredi JP and Sparks HV Jr. Adenosine's role in coronary vasodilation induced by atrial pacing and norepinephrine. Am J Physiol Heart Circ Physiol 243: H536-H545, 1982.
130. Matsunaga T, Okumura K, Tsunoda R, Tayama S, Tabuchi T, and Yasue H. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol Heart Circ Physiol 270: H427-H434, 1996.
131. Mayrovitz HN and Roy J. Microvascular blood flow: evidence indicating a cubic dependence on arteriolar diameter. Am J Physiol Heart Circ Physiol 245: H1031-H1038, 1983.
132. McCully JD, Uematsu M, Parker RA, and Levitsky S. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg 116: 154-162, 1998.
133. McKenzie JE, Steffen RP, and Haddy FJ. Relationships between adenosine and coronary resistance in conscious exercising dogs. Am J Physiol Heart Circ Physiol 242: H24-H29, 1982.
134. McKenzie JE, Steffen RP, and Haddy FJ. Effect of theophylline on adenosine production in the canine myocardium. Am J Physiol Heart Circ Physiol 252: H204-H210, 1987.
135. McRaven DR, Mark AL, Abboud FM, and Mayer HE. Responses of coronary vessels to adrenergic stimuli. J Clin Invest 50: 773-778, 1971.
136. Merkus D, Duncker DJ, and Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol 283: H1915-H1921, 2002.
137. Merkus D, Haitsma DB, Fung TY, Assen YJ, Verdouw PD, and Duncker DJ. Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways. Am J Physiol Heart Circ Physiol 285: H424-H433, 2003.
138. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, and Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745-754, 2003.
139. Merrill GF, Downey HF, and Jones CE. Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol Heart Circ Physiol 250: H579-H583, 1986.
140. Ming Z, Parent R, Thorin E, and Lavallee M. Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs. Hypertension 32: 844-848, 1998.
141. + channels. Circ Res 83: 501-507, 1998.
142. Miyashiro JK and Feigl EO. Feedforward control of coronary blood flow via coronary β-receptor stimulation. Circ Res 73: 252-263, 1993.
143. Miyashiro JK and Feigl EO. A model of combined feedforward and feedback control of coronary blood flow. Am J Physiol Heart Circ Physiol 268: H895-H908, 1995.
144. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 70: 612-616, 1992.
145. Mohrman DE and Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79-86, 1978.
146. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
147. Mori H, Chujo M, Tanaka E, Yamakawa A, Shinozaki Y, Mohamed MU, and Nakazawa H. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel. Am J Physiol Heart Circ Physiol 268: H1077-H1085, 1995.
148. Morita K, Mori H, Tsujioka K, Kimura A, Ogasawara Y, Goto M, Hiramatsu O, Kajiya F, and Feigl EO. α-Adrenergic vasoconstriction reduces systolic retrograde coronary blood flow. Am J Physiol Heart Circ Physiol 273: H2746-H2755, 1997.
149. Murray PA and Vatner SF. α-Adrenoceptor attenuation of the coronary vascular response to severe exercise in the conscious dog. Circ Res 45: 654-660, 1979.
150. Nakae I, Quan L, Sugimoto Y, Tsutamoto T, and Kinoshita M. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia. J Cardiovasc Pharmacol 23: 473-479, 1994.
151. + channel activation. Am J Physiol Heart Circ Physiol 265: H1289-H1293, 1993.
152. Nayler WG and Carson V. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade. Cardiovasc Res 7: 22-29, 1973.
153. Nichols CG and Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol Heart Circ Physiol 261: H1675-H1686, 1991.
154. Niiya K, Uchida S, Tsuji T, and Olsson RA. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J Pharmacol Exp Ther 271: 14-19, 1994.
155. Nishikawa Y and Ogawa S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J Am Coll Cardiol 29: 85-92, 1997.
156. Nishikawa Y, Stepp DW, and Chilian WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol Heart Circ Physiol 277: H1252-H1259, 1999.
157. Nishikawa Y, Stepp DW, and Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279: H459-H465, 2000.
158. + channels in cardiac muscle. Nature 305: 147-148, 1983.
159. Oltman CL, Kane NL, Fudge JL, Weintraub NL, and Dellsperger KC. Endothelium-derived hyperpolarizing factor in coronary microcirculation: responses to arachidonic acid. Am J Physiol Heart Circ Physiol 281: H1553-H1560, 2001.
160. + channels in the sustained coronary vasodilator response to adenosine in dogs. Eur J Pharmacol 231: 183-189, 1993.
161. Pacold I, Hwang MH, Lawless CE, Diamond P, Scanlon PJ, and Loeb HS. Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease. Am J Cardiol 57: 912-915, 1986.
162. Parent R, Al-Obaidi M, and Lavallée M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 73: 241-251, 1993.
163. Parent R, Hamdad N, Ming Z, and Lavallée M. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res 31: 555-567, 1996.
164. Parent R and Lavallée M. Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs. Cardiovasc Res 45: 470-477, 2000.
165. Parent R, Paré R, and Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol Heart Circ Physiol 262: H10-H16, 1992.
166. Parkington HC, Tonta MA, Coleman HA, and Tare M. Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle. J Physiol 484: 469-480, 1995.
167. Peic LR, Gross GJ, and Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 83: 2048-2056, 1991.
168. Popp R, Fleming I, and Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res 82: 696-703, 1998.
169. Quillen J, Seilke F, Banitt P, and Harrison D. The effect of norepinephrine on the coronary microcirculation. J Vasc Res 29: 2-7, 1992.
170. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, and Cannon ROI. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92: 320-326, 1995.
171. Randhawa MP, Lasley RD, and Mentzer RM Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg 110: 63-74, 1995.
172. +-ATP channels in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 277: H2115-H2123, 1999.
173. + channels and adenosine in the control of coronary blood flow during exercise. J Appl Physiol 89: 529-536, 2000.
174. Roberts PA, Newby AC, Hallett MB, and Campbell AK. Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes. Biochem J 227: 669-674, 1985.
175. Rosolowsky M and Campbell WB. Synthesis of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1299: 267-277, 1996.
176. Saetrum OO, Cantera L, Adner M, and Edvinsson L. Endothelin-A and -B receptors in human coronary arteries and veins. Regul Pept 63: 149-156, 1996.
177. Samaha FF, Heineman FW, Ince C, Fleming J, and Balaban RS. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol Cell Physiol 262: C1220-C1227, 1992.
178. Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, and Ross J Jr. Intracoronary a2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62: 436-442, 1988.
179. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, and Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res 76: 82-94, 1995.
180. Shen W, Lundborg M, Wang J, Stewart JM, Xu X, Ochoa M, and Hintze TH. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs. J Appl Physiol 77: 165-172, 1994.
181. Smith TP Jr and Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 73: 232-240, 1993.
182. + channels in arterial smooth muscle. Science 245: 177-180, 1989.
183. Stepp DW, Kroll K, and Feigl EO. K+ATP channels and adenosine are not necessary for coronary autoregulation. Am J Physiol Heart Circ Physiol 273: H1299-H1308, 1997.
184. Stepp DW, Nishikawa Y, and Chilian WM. Regulation of shear stress in the canine coronary microcirculation. Circulation 100: 1555-1561, 1999.
185. Stepp DW, Van Bibber R, Kroll K, and Feigl EO. Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res 79: 601-610, 1996.
186. 2- receptor-mediated dilation of isolated human coronary arterioles. Circulation 106: 550-555, 2002.
187. B-receptor blockade on coronary responses to treadmill exercise in dogs. J Appl Physiol 89: 2041-2048, 2000.
188. Takamura M, Parent R, and Lavallée B. Enhanced contribution of NO to exercise-induced coronary responses after α-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 282: H508-H515, 2002.
189. Tare M, Parkington HC, Coleman HA, Neild TO, and Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346: 69-71, 1990.
190. Tayama S, Okumura K, Matsunaga T, Tsunoda R, Tabuchi T, Iwasa A, and Yasue H. Influence of chronic nitric oxide inhibition of coronary blood flow regulation. A study of the role of endogenous adenosine in anesthetized, open-chest dogs. Jpn Circ J 62: 371-378, 1998.
191. Thorin E, Parent R, Ming Z, and Lavallée M. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans. Am J Physiol Heart Circ Physiol 277: H524-H532, 1999.
192. 1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665, 1992.
193. 1-adrenergic constriction. Circulation 98: 9-12, 1998.
194. Traverse JH, Judd D, and Bache RJ. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium. Circulation 93: 558-566, 1996.
195. Traverse JH, Wang YL, Du R, Nelson D, Lindstrom P, Archer SL, Gong G, and Bache RJ. Coronary nitric oxide production in response to exercise and endothelium-dependent agonists. Circulation 101: 2526-2531, 2000.
196. Tune JD, Richmond KN, Gorman MW, and Feigl EO. Role of nitric oxide and adenosine in control of coronary blood flow in exercising dogs. Circulation 101: 2942-2948, 2000.
197. + channels, nitric oxide, and adenosine are not required for local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 280: H868-H875, 2001.
198. Tune JD, Richmond KN, Gorman MW, Olsson RA, and Feigl EO. Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise. Am J Physiol Heart Circ Physiol 278: H74-H84, 2000.
199. Uematsu M, Gaudette GR, Laurikka JO, Levitsky S, and McCully JD. Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart. Ann Thorac Surg 66: 382-387, 1998.
200. Van Bibber R, Stepp DW, Kroll K, and Feigl EO. The role of adenosine in norepinephrine-induced coronary vasodilation. Am J Physiol Heart Circ Physiol 273: H557-H565, 1997.
201. Van Bibber R, Traub O, Kroll K, and Feigl EO. EDRF and norepinephfine-induced coronary vasodilation in the canine coronary circulation. Am J Physiol Heart Circ Physiol 268: H1973-H1981, 1995.
202. Wang J, Wolin MS, and Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res 73: 829-838, 1993.
203. Wangler RD, Gorman MW, Wang CY, Dewitt DF, Chan IS, Bassingthwaighte JB, and Sparks HV. Transcapillary adenosine transport and interstitial adenosine concentration in guinea pig hearts. Am J Physiol Heart Circ Physiol 257: H89-H106, 1989.
204. Watkinson WP, Foley DH, Rubio R, and Berne RM. Myocardial adenosine formation with increased cardiac performance in the dog. Am J Physiol Heart Circ Physiol 236: H13-H21, 1979.
205. Widmann MD, Weintraub NL, Fudge JL, Brooks LA, and Dellsperger KC. Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol Heart Circ Physiol 274: H283-H289, 1998.
206. Yada T, Richmond KN, Van Bibber R, Kroll K, and Feigl EO. Role of adenosine in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol 276: H1425-H1433, 1999.
207. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
208. Zong P, Tune JD, Setty S, and Downey HF. Endogenous nitric oxide regulates right coronary blood flow during acute pulmonary hypertension in conscious dogs. Basic Res Cardiol 97: 392-398, 2002.
209. Zuberbuhler RC and Bohr DF. Responses of coronary smooth muscle to catecholamines. Circ Res 16: 431-440, 1965.
210. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun JZ, Sekili S, Tang XL, and Bolli R. Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects. Circulation 88: 2359-2369, 1993.